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The potential of polymeric heart valves (PHV) prostheses is to combine the hemodynamic
performances of biological valves with the durability of mechanical valves. The aim of this
work is to design and develop a new tri-leaﬂet prosthetic heart valve (HV) made from styrenic
block copolymers. A computational ﬁnite element model was implemented to optimize the
thickness of the leaﬂets, to improve PHV mechanical and hydrodynamic performances. Based
on the model outcomes, 8 prototypes of the designed valve were produced and tested in vitro
under continuous and pulsatile ﬂow conditions, as prescribed by ISO 5840 Standard. A spe-
cially designed pulse duplicator allowed testing the PHVs at diﬀerent ﬂow rates and frequency
conditions. All the PHVs met the requirements speciﬁed in ISO 5840 Standard in terms of both
regurgitation and eﬀective oriﬁce area (EOA), demonstrating their potential as HV prostheses.
Keywords: Heart valve prosthesis; ﬁnite element model; pulse duplicator; styrenic block
copolymers.
1. Introduction
Two categories of heart valve (HV) prostheses are currently available to substitute
severe insuﬃcient or stenotic native valves: mechanical HV prostheses (made from
synthetic hard materials) or biological HV prostheses (made from animal or human
tissues).1 The former show greater durability; on the other hand, they have non-
physiological ﬂow proﬁles and require daily anticoagulant treatment to avoid blood
clotting. The latter exhibit better ﬂuid dynamics and hemocompatibility perfor-
mances, but are characterized by limited durability and a signiﬁcant risk of failure
due to tissue degradation.1 Despite developments in the manufacture of HV pros-
theses, long-term clinical applications require a new generation of prostheses able to
meet both reliability and eﬀectiveness requirements.2 Fully polymeric heart valve
(PHV) prostheses have been widely studied in the past due to their promising
ability to replicate the function of native HVs; however, they are not currently used
for clinical applications due to their lack of reliability.2 Recently, new emerging
material technologies allowed the development of novel polymeric materials with
improved and tunable properties: styrenic block copolymer elastomers have a
suitable morphology (i.e., stiﬀ cylindrical micro-domains) which may mimic the
function and the anisotropic structure of collagen and elastin in the native valve.3–5
The aim of this work was to design, develop and test in vitro PHVs prototypes,
according to the outcomes of an ad-hoc implemented ﬁnite element model which
minimizes the state of stress of the PHV leaﬂet and optimizes the coaptation area to
avoid regurgitation.
2. Material and Methods
2.1. Finite element model
CADmodeling was used to draw the PHV leaﬂet shape (Fig. 1(a)) to ﬁt into the host
anatomy with appropriate coaptation of the leaﬂets when the valve is closed to avoid
backward ﬂow. The design of a biomorphic PHV depends on the shape of three critical
regions (Fig. 1(b)): Commissural Edge (CE), Free-Edge (FE) and leaﬂet curvature
Shape Edge (SE). NURBS-based CAD modeling was chosen to get ﬂexibility in the
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description of the valve geometry. An automatic procedure was developed using the
commercial scripting tool RhinoSCRIPT (Rhinoceros, McNeel & Assoc.): After set-
ting the PHV class (i.e., circular, symmetric, trileaﬂet), the anatomical ﬁtting
parameters (i.e., 20mm in diameter and 10mm in height) and a constant leaﬂet
thickness, the procedure calculates the NURBS parameterization of CE and FE. An
automatic non rigid registration procedure provides the NURBS surfaces which best
ﬁt the boundary curves CE and FE, keeping the thickness constraint (Fig. 1(b)). A
ﬁnite element model (Abaqusr, SIMULIA, Dessault Systemes) was developed to
analyze the mechanical behavior of the valve as a function of the leaﬂet thickness
(t24 ¼ 0:24mm, t35 ¼ 0:35mm and t60 ¼ 0:60mm). Each 3D solid model was dis-
cretized with about 3000 linear hexahedral elements (Fig. 1(c)).
A single leaﬂet was considered, due to the valve geometry periodicity (120). The
mechanical eﬀect of the omitted leaﬂets was accounted by means of kinematic
constraints blocking displacement beyond the plane of symmetry of the PHV.
All the displacements at the CE were avoided to simulate the presence of the
valve stent. Uniform static pressure (24 kPa) was applied over the concave face of
the leaﬂet to simulate the maximum transvalvular pressure gradient (diastolic
load). The polymer mechanical behavior was modeled by a newly formulated
hyperelastic anisotropic constitutive law6,7; the strain energy function consists of
the sum of three terms: a term referring to a volumetric change of the material
( vol), the contribution of an isotropic matrix ( iso), and a term which takes into
account the presence of stiﬀ polymeric micro-domains ( aniso) oriented along the
circumferential direction. This orientation is speciﬁed by the unit vector a0, which
appears in the deﬁnition of I4:
ðC; a0Þ ¼ volðJÞ þisoðI 1; I 2Þ þanisoðI 4Þ: ð1Þ
Volumetric contribution
volðJÞ ¼
K
4
ðJ2  1 2 log JÞ: ð2Þ
Fig. 1. PHV CAD model: (a) Sketch of a trileaﬂet HV; (b) automatic drawing procedure to model the
edges (FE ¼ free edge, CE ¼ commissure Edge, SE ¼ shape edge); (c) 3D solid model of the leaﬂet.
A Newly Developed Tri-Leaﬂet PHV Prosthesis
1540009-3
J. 
M
ec
h.
 M
ed
. B
io
l. 
20
15
.1
5.
 D
ow
nl
oa
de
d 
fro
m
 w
w
w
.w
or
ld
sc
ie
nt
ifi
c.c
om
by
 C
A
M
BR
ID
G
E 
U
N
IV
ER
SI
TY
 o
n 
05
/2
1/
15
. F
or
 p
er
so
na
l u
se
 o
nl
y.
Isotropic contribution (Mooney-Rivlin)
isoðI 1; I 2Þ ¼ c1ðI 1  3Þ þ c2ðI 2  3Þ: ð3Þ
Anisotropic contribution6,7
anisoðI 4Þ ¼ k4 log2
ﬃﬃﬃﬃﬃ
I 4
q
; ð4Þ
where K is the bulk modulus (penalty coeﬃcient of volumetric changes), c1 and c2
are constants related to the shear modulus of the material. The model parameters
K, c1, c2 and k4 were ﬁtted to experimental data.
5
2.2. Prototype in vitro testing
Based on the CAD design and ﬁnite element model outcomes, 8 PHV prototypes
(Fig. 2) were manufactured by compression molding from poly(styrene-isoprene/
butadiene-styrene), with 19% polystyrene weight fraction.
(a)
(b)
Fig. 2. PHV prototype design: (a) Sketch of the PHV: hleaflet ¼ 10:8mm; htot ¼ 21mm; Dint ¼ 22mm;
Dext ¼ 28mm; (b) prototype of a PHV obtained by compression molding.
F. De Gaetano et al.
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In vitro tests were performed under both continuous and pulsatile ﬂow on a test
bench8,9 as recommended by ISO 5840 Standard,10 using distilled water at 25C.
Steady tests were performed at ﬂow rates from 0 to 10 L/min (steps 0.5 L/min).
Regurgitation tests were run applying a backpressure in the range of 28–128mmHg
(steps 5mmHg). A pulse duplicator was speciﬁcally designed to perform pulsatile
ﬂow tests replicating the peripheral compliance and the resistances of the cardio-
vascular system by a resistance-compliance-resistance (RCR) analogue.8,9 Each
PHV was tested under three diﬀerent frequencies (45 bpm, 70 bpm, 120 bpm), three
backpressures (80mmHg, 120mmHg, 160mmHg) and four mean ﬂow rates (2 L/
min, 3.5 L/min, 5 L/min and 7L/min), as required by the ISO 5840 Standard for at
least 15 cycles.
3. Results and Discussion
3.1. Finite element model results
Finite element analyses were performed on t24, t35 and t60 models to calculate the
stress distribution within the leaﬂet (Fig. 3). Due to the leaﬂet symmetry, all models
show a symmetrical distribution of stress. Under the diastolic load, all the leaﬂet
geometries assure appropriate coaptation of the leaﬂets, while t24 shows a signiﬁ-
cant stress increase near the junction between FE and commissural region. Model
t60 presents no signiﬁcant stress peaks but a reduced coaptation area; moreover, the
thickness of the leaﬂet may limit opening and closing of the PHV. Model t35 seems
to be the best compromise amongst the analyzed geometries.
3.2. In vitro tests results
Mean transvalvular pressure drop (8:36 1:33mmHg) and mean regurgitation
(175:3 19mL/min) were recorded during continuous ﬂow and static regurgitation
tests.
Figures 4(a) and 4(b) shows minimal leakage area formed during static regur-
gitation tests.
(a) (b)
Fig. 3. Computational outcomes as a function of the leaﬂet thickness: (a) Coaptation area; (b) Von
Mises stress [MPa].
A Newly Developed Tri-Leaﬂet PHV Prosthesis
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During pulsatile ﬂow tests mean (12:20 1:41mmHg) and maximum (30:09
4:7mmHg) systolic pressure diﬀerences were recorded.
Regurgitation (7:13% 1:33) and EOA (1:445 0:08 cm2) of all the PHVs meet
the requirements deﬁned by ISO 5840 Standard (i.e., regurgitation < 10% of the
stroke volume and EOA > 1 cm2 for a 23mm valve).
4. Conclusion
The computational model implemented in this study can be used as a tool for the
optimization of the design of new PHVs: The automatic parametric CAD procedure
allows a wide variety of leaﬂet designs to be investigated and the standardized ﬁnite
element model procedure gives information about the mechanical response of the
device before prototyping. In this study the model was used to deﬁne the optimal
leaﬂet thickness (t ¼ 0:35mm), able to maximize the coaptation area while reducing
the stress on the leaﬂet. With the same approach, the model can be used to
investigate the inﬂuence of other geometrical parameters (e.g., leaﬂet height,
curvature, commissure shape, etc.) and of the material properties. Block copoly-
mers based on styrene are promising materials for PHV prostheses thanks to their
(a) (b)
(c) (d)
Fig. 4. In vitro tests results: (a) and (b) PHVs during static regurgitation tests at backpressure
28mmHg (a) and 128mmHg (b); (c) Pressure and ﬂow courses of the PHV during pulsatile tests; (d)
maximum opening of the PHV.
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features of mechanical stability, biocompatibility and the possibility to achieve
tailored anisotropy. The arrangement of the micro-domains can be optimized to
enhance the valve durability under physiological stress conditions.
The experimental hydrodynamic evaluation of PHV prototypes showed all 8
PHVs meet the minimum requirements speciﬁed by the standard10 in terms of both
regurgitation and EOA. The tests proved that the performance of these new PHV is
comparable with the performances of some bi-leaﬂet mechanical prostheses cur-
rently used in clinics, having a comparable tissue annulus diameter.11 However,
design improvements in terms of polymer cylindrical domain orientation and
molding techniques are ongoing to further minimize regurgitation and maximize
EOA. In vitro fatigue tests are also ongoing to prove PHV long term reliability
before performing in vivo animal trials, necessary to deﬁnitely assess the PHV
suitability for clinical applications.
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